Patents by Inventor Roberta Razzetti

Roberta Razzetti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of pulmonary surfactants in lung transplantation and methods thereof
    Patent number: 9402603
    Abstract: The present invention concerns a method of treating an advanced lung disease in a patient in need thereof by lung transplantation.
    Type: Grant
    Filed: January 8, 2013
    Date of Patent: August 2, 2016
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Federico Bianco, Roberta Razzetti, Patrizio Vitulo, Alessandro Bertani
  • USE OF PULMONARY SURFACTANTS IN LUNG TRANSPLANTATION AND METHODS THEREOF
    Publication number: 20140128846
    Abstract: The present invention concerns a method of treating an advanced lung disease in a patient in need thereof by lung transplantation.
    Type: Application
    Filed: January 8, 2013
    Publication date: May 8, 2014
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Federico BIANCO, Roberta Razzetti, Patrizio Vitulo, Alessandro Bertani
  • Therapeutic combination comprising a pulmonary surfactant and a steroid
    Patent number: 8357657
    Abstract: Administration of a modified natural surfactant in combination with a corticosteroid is effective for the prevention of bronchopulmonary dysplasia (BPD) and lowers the markers of pulmonary oxidative stress.
    Type: Grant
    Filed: May 25, 2010
    Date of Patent: January 22, 2013
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Massimo Giossi, Roberta Razzetti, Paolo Chiesi
  • THERAPEUTIC COMBINATION COMPRISING A PULMONARY SURFACTANT AND A STEROID
    Publication number: 20110130333
    Abstract: Administration of a modified natural surfactant in combination with a corticosteroid is effective for the prevention of bronchopulmonary dysplasia (BPD) and lowers the markers of pulmonary oxidative stress.
    Type: Application
    Filed: May 25, 2010
    Publication date: June 2, 2011
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Massimo GIOSSI, Roberta Razzetti, Paolo Chiesi
  • COMPOSITIONS COMPRISING AN ANTIMUSCARINIC AND A LONG-ACTING BETA-AGONIST
    Publication number: 20090181935
    Abstract: Compositions which comprise a combination of a salt of 3-[[[(3-fluorophenyl)[(3,4,5-trifluoro phenyl)methyl]amino]carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo [2.2.2]octane, and a long-acting phenylalkylamino beta2-agonist are effective for the prevention and treatment of inflammatory or obstructive airways diseases.
    Type: Application
    Filed: December 24, 2008
    Publication date: July 16, 2009
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Gino Villetti, Roberta Razzetti
  • Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients
    Publication number: 20070020190
    Abstract: The present invention relates to the use of a bronchodilator in combination with one or more further active ingredients for the treatment of respiratory disorders and especially asthma and chronic obstructive pulmonary disease (COPD), and to pharmaceutical compositions containing said active ingredients. In particular, the invention relates to the use of the long-acting ?2-agonist 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1methylethyl]amino]ethyl-2(1H)quinolinone and/or physiologically acceptable salts and/or solvates thereof as a bronchodilator in combination with other active ingredients.
    Type: Application
    Filed: February 27, 2004
    Publication date: January 25, 2007
    Inventors: Roberta Razzetti, Fiorella Pastore
  • Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions
    Publication number: 20060229365
    Abstract: The use of 5,6-dihydroxy-2-methylaminotetralin (CHF 1035) and of 5,6-diisobutyroyloxy-2-methylaminotetralin (CHF 1024) for the preparation of a medicament for the treatment and prevention of myocardial ischemic conditions.
    Type: Application
    Filed: June 12, 2006
    Publication date: October 12, 2006
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Giuseppe Rossoni, Roberta Razzetti
  • 2-Aminotetralin derivatives for the therapy of glaucoma
    Patent number: 6953813
    Abstract: The use of racemic or optically active compounds represented by formula (I) and the salts thereof wherein R is H or CH3 for the preparation of pharmaceutical compositions for the therapy of ophthalmic disorders.
    Type: Grant
    Filed: July 26, 2000
    Date of Patent: October 11, 2005
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Stefano Bongrani, Roberta Razzetti, Paolo Chiesi
  • Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions
    Publication number: 20050101668
    Abstract: The use of 5,6-dihydroxy-2-methylaminotetralin (CHF 1035) and of 5,6-diisobutyroyloxy-2-methylaminotetralin (CHF 1024) for the preparation of a medicament for the treatment and prevention of myocardial ischemic conditions.
    Type: Application
    Filed: July 23, 2004
    Publication date: May 12, 2005
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Giuseppe Rossoni, Roberta Razzetti
  • Optically active2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
    Publication number: 20040102652
    Abstract: The use of the optically active forms of 5,6-dihydroxy-2-methylaminotetralin and acyl esters thereof as medicaments for cardiovascular diseases a process for the preparation thereof and their use in pharmaceutical compositions.
    Type: Application
    Filed: June 9, 2003
    Publication date: May 27, 2004
    Inventors: Gabriele Amari, Maurizio Del Canale, Roberta Razzetti, Pier Alessandro Monici Preti, Ivano Rondelli
  • Aminotetralin derivative for the therapy of cardiovascular diseases
    Publication number: 20030207944
    Abstract: Left ventricular dysfunction is treated by a process, comprising: administering to a subject suffering from left ventricular remodeling a therapeutically effective amount of 5,6-dihydroxy-2-methylaminotetralin, or 5,6-diisobutyroyl-oxy-2-methyl-aminotetralin, or a pharmaceutically acceptable salt thereof in combination with an angiotensin-converting enzyme inhibitor.
    Type: Application
    Filed: April 11, 2003
    Publication date: November 6, 2003
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Stefano Bongrani, Roberta Razzetti, Maurizio Civelli, Alberto Umile, Paolo Chiesi
  • Aminotetralin derivatives for the therapy of cardiovascular diseases
    Patent number: 6576671
    Abstract: The invention relates to a method of treatment of left ventricular dysfunction, by administering to a subject suffering from left ventricular remodeling a therapeutically effective amount of 5,6-dihydroxy-2-methylaminotetralin or 5,6-diisobutyroyl-oxy-2-methyl-aminotetralin, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 19, 2002
    Date of Patent: June 10, 2003
    Assignee: Chiese Farmaceutici S.p.A.
    Inventors: Stefano Bongrani, Roberta Razzetti, Maurizio Civelli, Alberto Umile, Paolo Chiesi
  • Aminotetralin derivative for the therapy of cardiovascular diseases
    Patent number: 6103760
    Abstract: Left ventricular dysfunction is treated by a process, comprising:administering to a subject suffering from left ventricular remodeling a therapeutically effective amount of 5,6-dihydroxy-2-methylaminotetralin, or 5,6-diisobutyroyl-oxy-2-methyl-aminotetralin, or a pharmaceutically acceptable salt thereof in combination with an angiotensin-converting enzyme inhibitor.
    Type: Grant
    Filed: June 9, 1999
    Date of Patent: August 15, 2000
    Assignee: Chiesi Farmaceuticals S.p.A.
    Inventors: Paolo Chiesi, Stefano Bongrani, Roberta Razzetti, Maurizio Civelli, Alberto Umile
  • Aminotetralin derivative for the therapy of cardiovascular diseases
    Patent number: 6013678
    Abstract: A method of treating congestive heart failure is diclosed comprising administering 5,6-dihydroxy- or 5,6-diisobutyroyloxy-2-methylaminotetralin or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 14, 1997
    Date of Patent: January 11, 2000
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Paolo Chiesi, Stefano Bongrani, Roberta Razzetti, Maurizio Civelli, Alberto Umile
  • Thiomethyl and sulfinylmethyl derivatives having gastric acid antisectetory activity and pharmaceutical compositions containing them
    Patent number: 5066652
    Abstract: Compounds of the formulaHet-S(O).sub.n -CH.sub.2 -A (I)wherein Het is a substituted imidazolyl, purinyl, thieno-imidazolyl or imidazo-pyridyl group, n is 0 or 1, A is one of the following structures: ##STR1## and their physiologically acceptable salts have antiulcer and gastric acid antisecretory activity.
    Type: Grant
    Filed: March 14, 1990
    Date of Patent: November 19, 1991
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Paolo Chiesi, Vittorino Servadio, Roberta Razzetti